{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:59:32Z","timestamp":1790895572602,"version":"4.1.0"},"reference-count":30,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T00:00:00Z","timestamp":1507593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:p>Authorized generics are identical in formulation to brand drugs, manufactured by the brand company but marketed as a generic. Generics, marketed by generic manufacturers, are required to demonstrate pharmaceutical and bioequivalence to the brand drug, but repetition of clinical trials is not required. This retrospective cohort study compared outcomes for generics and authorized generics, which serves as a generic vs. brand proxy that minimizes bias against generics. For the seven drugs studied between 1999 and 2014, 5,234 unique patients were on brand drugs prior to generic entry and 4,900 (93.6%) switched to a generic. During the 12 months following the brand\u2010to\u2010generic switch, patients using generics vs. authorized generics were similar in terms of outpatient visits, urgent care visits, hospitalizations, and medication discontinuation. The likelihood of emergency department (ED) visits was slightly higher for authorized generics compared with generics. These data suggest that generics were clinically no worse than their proxy brand comparators.<\/jats:p>","DOI":"10.1002\/cpt.591","type":"journal-article","created":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T14:10:10Z","timestamp":1481983810000},"page":"310-317","source":"Crossref","is-referenced-by-count":18,"title":["Comparison of Outcomes Following a Switch From a Brand to an Authorized Versus Independent Generic Drug"],"prefix":"10.1111","volume":"103","author":[{"given":"RA","family":"Hansen","sequence":"first","affiliation":[{"name":"Auburn University, Harrison School of Pharmacy, Department of Health Outcomes Research and Policy Auburn Alabama USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Qian","sequence":"additional","affiliation":[{"name":"Auburn University, Harrison School of Pharmacy, Department of Health Outcomes Research and Policy Auburn Alabama USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RL","family":"Berg","sequence":"additional","affiliation":[{"name":"Marshfield Clinic Research Foundation Biomedical Informatics Research Center Marshfield Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JG","family":"Linneman","sequence":"additional","affiliation":[{"name":"Marshfield Clinic Research Foundation Biomedical Informatics Research Center Marshfield Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Seoane\u2010Vazquez","sequence":"additional","affiliation":[{"name":"Massachusetts College of Pharmacy and Health Sciences International Center for Pharmaceutical Economics and Policy Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Dutcher","sequence":"additional","affiliation":[{"name":"US Food and Drug Administration Office of Generic Drugs Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Raofi","sequence":"additional","affiliation":[{"name":"US Food and Drug Administration Office of Generic Drugs Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CD","family":"Page","sequence":"additional","affiliation":[{"name":"University of Wisconsin, School of Medicine and Public Health, Department of Biostatistics and Medical Informatics, and Department of Computer Science Madison Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PL","family":"Peissig","sequence":"additional","affiliation":[{"name":"Marshfield Clinic Research Foundation Biomedical Informatics Research Center Marshfield Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,10,10]]},"reference":[{"key":"e_1_2_9_1_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.872"},{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-11-200506070-00006"},{"key":"e_1_2_9_3_1","unstructured":"Generic Pharmaceutical Association.Generic drug savings in the U.S. \u2013 Fifth Annual Edition.<http:\/\/www.gphaonline.org\/media\/cms\/2013_Savings_Study_12.19.2013_FINAL.pdf> (2013)."},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.7326\/M13-2942"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.3.332"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2005.12.010"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03399.x"},{"key":"e_1_2_9_8_1","unstructured":"U.S. Food and Drug Administration.How drugs are developed and approved.<http:\/\/www.fda.gov\/Drugs\/DevelopmentApproval Process\/HowDrugsareDevelopedandApproved\/default.htm> (2014)."},{"key":"e_1_2_9_9_1","unstructured":"U.S. Food and Drug Administration.Abbreviated new drug application (ANDA): generics.<http:\/\/www.fda.gov\/Drugs\/DevelopmentApproval Process\/HowDrugsareDevelopedandApproved\/ApprovalApplications\/AbbreviatedNewDrugApplicationANDAGenerics\/default.htm> (2014)."},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2008.06.001"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.5888\/pcd9.120010"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2011.12.004"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.28.2.546"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-141-2-200407200-00011"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-6773.2006.00579.x"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-013-0042-z"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1037\/hea0000282"},{"key":"e_1_2_9_18_1","unstructured":"U.S. Food and Drug Administration.List of authorized generic drugs.<http:\/\/www.fda.gov\/drugs\/developmentapprovalprocess\/howdrugsaredevelopedandapproved\/approvalapplications\/abbreviatednewdrugapplicationandagenerics\/ucm126389.htm> (2014)."},{"key":"e_1_2_9_19_1","unstructured":"Federal Trade Commission.Authorized generic drugs: short\u2010term effects and long\u2010term impact.<https:\/\/www.ftc.gov\/sites\/default\/files\/documents\/reports\/authorized\u2010generic\u2010drugs\u2010short\u2010term\u2010effects\u2010and\u2010long\u2010term\u2010impact\u2010report\u2010federal\u2010trade\u2010commission\/authorized\u2010generic\u2010drugs\u2010short\u2010term\u2010effects\u2010and\u2010long\u2010term\u2010impact\u2010report\u2010federal\u2010trade\u2010commission.pdf> (2011)."},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2009.10.001"},{"key":"#cr-split#-e_1_2_9_21_1.1","unstructured":"Pratt L.A. Brody D.J.&Gu Q.Antidepressant use in persons aged 12 and over: United States 2005-2008. National Center for Health Statistics Centers for Disease Control and Prevention. 2011"},{"key":"#cr-split#-e_1_2_9_21_1.2","unstructured":"NCHS Data Brief No. 76. <http:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db76.pdf> (2011)."},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-015-0374-7"},{"key":"e_1_2_9_23_1","unstructured":"U.S. Food and Drug Administration.Update: bupropion hydrochloride extended\u2010release 300 mg bioequivalence studies.<http:\/\/www.fda.gov\/drugs\/drugsafety\/postmarketdrugsafetyinformationforpatientsandproviders\/ucm322161.htm> (2013)."},{"key":"e_1_2_9_24_1","unstructured":"U.S. Food and Drug Administration.Methylphenidate hydrochloride extended release tablets (generic Concerta) made by Mallinckrodt and Kudco.<http:\/\/www.fda.gov\/drugs\/drugsafety\/ucm422568.htm> (2014)."},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.359"},{"key":"e_1_2_9_26_1","first-page":"1006","article-title":"Adherence and persistence among chronic myeloid leukemia patients during second\u2010line tyrosine kinase inhibitor treatment","volume":"20","author":"Trivedi D.","year":"2014","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2014.933577"},{"key":"e_1_2_9_28_1","unstructured":"World Health Organization.Defined daily dose definition and general considerations. <http:\/\/www.whocc.no\/ddd\/definition_and_general_considera\/>."},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq433"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcpt.591","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcpt.591","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.591","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:34:57Z","timestamp":1699364097000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,10]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1002\/cpt.591"],"URL":"https:\/\/doi.org\/10.1002\/cpt.591","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,10]]}}}